Cardiovascular Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cardiovascular Disease stocks.

Cardiovascular Disease Stocks Recent News

Date Stock Title
May 8 XENE Xenon Pharma Q1 2024 Earnings Preview
May 8 XENE Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
May 8 SMLR Semler Scientific: Great Product Can Still Thrive Post Medicare Advantage
May 8 VERV Verve Therapeutics GAAP EPS of -$0.59 beats by $0.12, revenue of $5.7M beats by $3.45M
May 8 SMLR Semler Scientific, Inc. (NASDAQ:SMLR) Q1 2024 Earnings Call Transcript
May 8 NBIX Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults
May 8 REGN Regeneron gene therapy improves hearing in child deafness
May 8 VERV Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates
May 8 NNOX USARAD, Nanox’s Teleradiology Subsidiary, Awarded Accreditation from The Joint Commission
May 8 REGN Regeneron gene therapy improves hearing in two children
May 8 VERV Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
May 8 REGN Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
May 7 SMLR Semler Scientific, Inc. (SMLR) Q1 2024 Earnings Call Transcript
May 7 XOMA Certara, Inc. (CERT) Q1 Earnings Meet Estimates
May 7 SMLR Semler Scientific Inc (SMLR) Q1 Earnings: Mixed Results Amid Revenue Decline and Net Income Growth
May 7 SMLR Semler Scientific GAAP EPS of $0.78 misses by $0.25, revenue of $15.9M misses by $5.5M
May 7 NBIX Neurocrine Biosciences to Present at the BofA Securities 2024 Health Care Conference
May 7 XENE Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference
May 7 SMLR Semler Scientific® Reports First Quarter 2024 Financial Results
May 7 XOMA Xoma (XOMA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Cardiovascular Disease

Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Cardiovascular disease includes coronary artery diseases (CAD) such as angina and myocardial infarction (commonly known as a heart attack). Other CVDs include stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.The underlying mechanisms vary depending on the disease. Coronary artery disease, stroke, and peripheral artery disease involve atherosclerosis. This may be caused by high blood pressure, smoking, diabetes, lack of exercise, obesity, high blood cholesterol, poor diet, and excessive alcohol consumption, among others. High blood pressure results in 13% of CVD deaths, while tobacco results in 9%, diabetes 6%, lack of exercise 6% and obesity 5%. Rheumatic heart disease may follow untreated strep throat.It is estimated that 90% of CVD is preventable. Prevention of atherosclerosis involves improving risk factors through: healthy eating, exercise, avoidance of tobacco smoke and limiting alcohol intake. Treating risk factors, such as high blood pressure, blood lipids and diabetes is also beneficial. Treating people who have strep throat with antibiotics can decrease the risk of rheumatic heart disease. The use of aspirin in people, who are otherwise healthy, is of unclear benefit.Cardiovascular diseases are the leading cause of death globally. This is true in all areas of the world except Africa. Together they resulted in 17.9 million deaths (32.1%) in 2015, up from 12.3 million (25.8%) in 1990. Deaths, at a given age, from CVD are more common and have been increasing in much of the developing world, while rates have declined in most of the developed world since the 1970s. Coronary artery disease and stroke account for 80% of CVD deaths in males and 75% of CVD deaths in females. Most cardiovascular disease affects older adults. In the United States 11% of people between 20 and 40 have CVD, while 37% between 40 and 60, 71% of people between 60 and 80, and 85% of people over 80 have CVD. The average age of death from coronary artery disease in the developed world is around 80 while it is around 68 in the developing world. Disease onset is typically seven to ten years earlier in men as compared to women.

Browse All Tags